Regeneron Pharmaceuticals (REGN)

$725.05 0.05 (0.01%)

16:00 EDT REGN Stock Quote Delayed 30 Minutes

The 7 Growth Stocks You Need to Own Now for Maximum Returns

By Josh Enomoto, InvestorPlace Contributor May 17, 2023

If you still want to stick around in the market for max returns, these growth stocks to buy should be intriguing for speculators.

The Greatest 7 Blue-Chip Stocks to Buy for Your Portfolio

REGN Stock Alert: Regeneron Pharmaceuticals Gains on Dupixent Drug Data

7 Value Stocks Worth Buying at These 52-Week Highs

Volume:

Previous Close -

Market Cap 66.54B

PE Ratio 19.71

EPS 36.79

Volume (Avg. Vol.) 750,770

Day's Range $719.00 - $726.77

52-Week Range $538.01 - $837.55

Dividend & Yield N/A (N/A)

REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News

From InvestorPlace
From the Web

The 7 Best Biotech Stocks to Buy for February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 7, 2023

Following the wave of red ink last year, astute investors should target the best biotech stocks to buy this month for strong growth potential.

The 7 Most Undervalued Stocks to Buy in February 2023

By Alex Sirois Feb 2, 2023

February's undervalued stocks span the gamut of industry and have substantial upside that can provide quick returns.

The 7 Most Undervalued Biotech Stocks to Buy in February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 2, 2023

Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.

The 7 Most Undervalued Nasdaq Stocks to Buy in February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 1, 2023

For those seeking the best discounts in the tech-centered index, these are the most undervalued Nasdaq stocks to buy.

5 Top Pharma Stocks of 2022 to Buy for the Long Haul

By Dana Blankenhorn, InvestorPlace Contributor Jan 6, 2023

The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.

7 Undervalued Biotech Stocks to Buy Before They Boom

By Josh Enomoto, InvestorPlace Contributor Dec 29, 2022

While medical innovations offer tremendous appeal, investors can still get a discount in this sector via undervalued biotech stocks to buy.

Our 7 Top Biotech Stock Picks for 2023

By Josh Enomoto, InvestorPlace Contributor Dec 9, 2022

Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023.

Why Is CytomX Therapeutics (CTMX) Stock Up 29% Today?

By William White, InvestorPlace Writer Nov 17, 2022

CytomX Therapeutics (CTMX) stock is rising higher on Wednesday after announcing a partnership with Regeneron Pharmaceuticals (REGN).

7 Cash-Rich Stocks to Buy for Peace of Mind

By Will Ashworth, InvestorPlace Contributor Nov 4, 2022

It pays to hold cash-rich stocks that can weather any storm because of their financial strength. These seven stocks are such companies.

These 7 Biotech Stocks Are Set to Boom in 2023

By Chris Markoch, InvestorPlace Contributor Oct 10, 2022

This article looks at seven biotech stocks that look like good options to move significantly higher in 2023

The 3 Best Healthcare Stocks to Buy Now

By Larry Ramer, InvestorPlace Contributor Sep 9, 2022

Investors are less worried about the regulation of the U.S. healthcare sector, making this a good time to buy the best healthcare stocks.

5 Top Stocks Cathie Wood Is Selling This Week

By Eddie Pan, InvestorPlace Assistant News Writer Aug 26, 2022

Cathie Wood's ARKK received $54.2 million of inflows earlier this month, the most in a five-day period since May. Here's what she's selling.

7 Cathie Wood Stocks to Buy on the Dip

By Alex Sirois Aug 22, 2022

Cathie Wood stocks lost some of their shine in the tech wreck. But the second half of 2022 looks much brighter for these picks.

3 Biotech Stocks Outperforming a Bear Market

By Jaimini Desai Jul 15, 2022

These biotech stocks are the most attractive from a valuation and growth perspective as they are less impacted by a slowing economy or change in monetary policy.

7 Safe Stocks to Buy to Guard Against a Recession

By Louis Navellier and the InvestorPlace Research Staff Apr 5, 2022

It's not too late to buy safe stocks. These seven stocks, all A-rated, are perfect plays for riding out continued volatility in the markets.

Upcoming Stock Splits 2022: 20 Companies That Could Follow Amazon’s Lead

By William White, InvestorPlace Writer Mar 10, 2022

We're taking a gander at more companies that could follow Amazon's (AMZN) lead with potential upcoming stock splits in 2022.

7 Low Volatility Stocks to Buy Right Now for Steady Returns

By Brian Paradza, CFA Feb 24, 2022

A great way to find low volatility stocks is to look for a beta that's less than 1.0. Here are seven to buy as market turbulence increases.

3 Biotech Stocks That Could Boom or Bust in Q1

By Joel Baglole, InvestorPlace Contributor Feb 1, 2022

The biotech industry is exploding. Biotech stocks provide lots of opportunities for investors who are taking a risk on the medicine's future.

Regeneron: Surfing on Covid, With More Under the Surface

By Dana Blankenhorn, InvestorPlace Contributor Dec 2, 2021

Regeneron has made billions from its Covid-19 drug, and it has new drugs like Dupixent that could make many billions more.

7 Biotech Stocks Entering the Golden Boom Phase

By Chris Lau, InvestorPlace Contributor Sep 28, 2021

These biotech stocks offer a more mature take on an otherwise risky sector. These companies already have successes under their belt.

Regeneron Pharmaceuticals (REGN)

The 7 Growth Stocks You Need to Own Now for Maximum Returns

The Greatest 7 Blue-Chip Stocks to Buy for Your Portfolio

REGN Stock Alert: Regeneron Pharmaceuticals Gains on Dupixent Drug Data

7 Value Stocks Worth Buying at These 52-Week Highs

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Regeneron Pharmaceuticals (REGN)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News

Subscriber Sign in